Mercato terapeutico del sistema nervoso centrale (SNC) in Sudafrica fino al 2027 - Analisi regionale e previsioni per tipo di malattia (malattie neurovascolari, disturbi degenerativi, salute mentale, traumi, altri); tipo di farmaco (analgesici, farmaci per il sistema nervoso, anestetici, farmaci anti-Parkinson, antiepilettici, altri); canale di distribuzione (farmacie ospedaliere, farmacie al dettaglio) e area geografica.

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027


No. of Pages: 76    |    Report Code: TIPRE00006580    |    Category: Life Sciences

Explore in Your Language
South Africa Central Nervous System (CNS) Therapeutic Market

Il mercato terapeutico del sistema nervoso centrale (SNC) in Sud Africa dovrebbe raggiungere 3.686,91 milioni di dollari nel 2027 da 2.267,59 milioni di dollari nel 2018. Si stima che il mercato crescerà con un CAGR del 5,6% dal 2019 al 2027 dal 2019 al 2027

.

 

Crescente prevalenza di malattie del sistema nervoso centrale come malnutrizione, malaria, virus dell\'immunodeficienza umana e malattie del sistema nervoso centrale. si prevede che la sindrome da immunodeficienza acquisita (HIV/AIDS) e le transizioni demografiche aumenteranno la crescita del mercato. Tuttavia, è probabile che l\'elevato costo delle cure abbia un impatto negativo sulla crescita del mercato nei prossimi anni.

 

I disturbi neurologici sono molto diffusi nell\'Africa subsahariana . I fattori responsabili del crescente onere includono situazioni perinatali difficili, malnutrizione, malaria, virus dell\'immunodeficienza umana e malattie gravi. la sindrome da immunodeficienza acquisita (HIV/AIDS) e le transizioni demografiche. I disturbi neurologici primari comprendono ritardo mentale, paralisi cerebrale, disturbi dello sviluppo, epilessia, neuropatia periferica, ictus, traumi e abuso di alcol. Secondo il South African Pharmaceutical Journal nel 2016, circa 818.106 persone ogni anno soffrono di demenza, che attualmente colpisce più di 4 milioni di persone. Si prevede che il numero supererà i 14 milioni entro il 2050. Inoltre, la demenza associata all\'HIV (HAD) è dominante nel 15-30% degli adulti non trattati con malattia in stadio avanzato. I pazienti anziani, che in precedenza avevano un rischio maggiore di demenze non correlate all\'AIDS, sono più inclini all\'HIV non trattato. Si prevede che una tale crescente prevalenza di disturbi del sistema nervoso centrale creerà una domanda per il sistema nervoso centrale (SNC) terapeutico in tutto il mondo.

 

Sistema nervoso centrale (SNC) del Sud Africa Il mercato terapeutico, in base al tipo di farmaco, è stato segmentato in analgesici, farmaci per il sistema nervoso, anestetici, farmaci antiparkinson, antiepilettici, altri. Nel 2018, il segmento degli analgesici deteneva la quota maggiore del mercato, per tipologia di farmaco. Si prevede inoltre che questo segmento cresca al ritmo più elevato durante il periodo di previsione perché vengono utilizzati per alleviare il dolore che fornisce sollievo ai pazienti senza perdere conoscenza.


Mostra: Sud Africa Drug Tipologia Entrate e previsioni di mercato fino al 2027 (milioni di dollari USA)


Terapeutico del sistema nervoso centrale (SNC) del Sud Africa - SEGMENTAZIONE DEL MERCATO

Per tipo di malattia

  • Malattie neurovascolari
  • Disturbi degenerativi
  • Salute mentale
  • Trauma
  • Altro

Per tipo di farmaco

  • analgesici
  • Farmaci del sistema nervoso
  • Anestetici
  • Farmaci anti-Parkinson
  • Antiepilettici
  • Altri

Per

canale di distribuzione

  • Farmacie ospedaliere
  • Farmacie al dettaglio
  •  

    Aziende menzionate

    • Eli Lilly e compagnia
    • Pfizer Inc.
    • Merck & Co., Inc.
    • AstraZeneca
    • Novartis AG
    • Takeda Pharmaceutical Company Limited
    • Teva Pharmaceutical Industries Ltd.
    • < li>Lundbeck
    • Adcock Ingram
    • Lupin Limited

     



    South Africa Central Nervous System (CNS) Therapeutic Strategic Insights

    Strategic insights for South Africa Central Nervous System (CNS) Therapeutic involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/south-africa-central-nervous-system-cns-therapeutic-market-strategic-framework.webp
    Get more information on this report

    South Africa Central Nervous System (CNS) Therapeutic Report Scope

    Report Attribute Details
    Market size in 2018 US$ 2,267.59 Million
    Market Size by 2027 US$ 3,686.91 Million
    Global CAGR (2019 - 2027) 5.6%
    Historical Data 2016-2017
    Forecast period 2019-2027
    Segments Covered By Tipo di malattia
    • malattie neurovascolari
    • disturbi degenerativi
    • salute mentale
    • traumi
    By Tipo di farmaco
    • analgesici
    • farmaci per il sistema nervoso
    • anestetici
    • farmaci anti-Parkinson
    • anti-epilettici
    By Canale di distribuzione
    • farmacie ospedaliere
    • farmacie al dettaglio
    Regions and Countries Covered Sudafrica
    • Sudafrica
    Market leaders and key company profiles
  • Eli Lilly and company
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AstraZeneca
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Lundbeck
  • Adcock Ingram
  • Lupin Limited
  • Get more information on this report

    South Africa Central Nervous System (CNS) Therapeutic Regional Insights

    The regional scope of South Africa Central Nervous System (CNS) Therapeutic refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-africa-central-nervous-system-cns-therapeutic-market-geography.webp
    Get more information on this report

The List of Companies - South Africa Central Nervous System (CNS) Therapeutic Market

The List of Companies

 

  1. Eli Lilly and company
  2. Pfizer Inc.
  3. Merck & Co., Inc.
  4. AstraZeneca
  5. Novartis AG
  6. Takeda Pharmaceutical Company Limited
  7. Teva Pharmaceutical Industries Ltd.
  8. Lundbeck
  9. Adcock Ingram
  10. Lupin Limited

 

Frequently Asked Questions
How big is the South Africa Central Nervous System (CNS) Therapeutic Market?

The South Africa Central Nervous System (CNS) Therapeutic Market is valued at US$ 2,267.59 Million in 2018, it is projected to reach US$ 3,686.91 Million by 2027.

What is the CAGR for South Africa Central Nervous System (CNS) Therapeutic Market by (2019 - 2027)?

As per our report South Africa Central Nervous System (CNS) Therapeutic Market, the market size is valued at US$ 2,267.59 Million in 2018, projecting it to reach US$ 3,686.91 Million by 2027. This translates to a CAGR of approximately 5.6% during the forecast period.

What segments are covered in this report?

The South Africa Central Nervous System (CNS) Therapeutic Market report typically cover these key segments-

  • Tipo di malattia (malattie neurovascolari, disturbi degenerativi, salute mentale, traumi)
  • Tipo di farmaco (analgesici, farmaci per il sistema nervoso, anestetici, farmaci anti-Parkinson, anti-epilettici)
  • Canale di distribuzione (farmacie ospedaliere, farmacie al dettaglio)
  • What is the historic period, base year, and forecast period taken for South Africa Central Nervous System (CNS) Therapeutic Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South Africa Central Nervous System (CNS) Therapeutic Market report:

  • Historic Period : 2016-2017
  • Base Year : 2018
  • Forecast Period : 2019-2027
  • Who are the major players in South Africa Central Nervous System (CNS) Therapeutic Market?

    The South Africa Central Nervous System (CNS) Therapeutic Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Eli Lilly and company
  • Pfizer Inc.
  • Merck & Co., Inc.
  • AstraZeneca
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Lundbeck
  • Adcock Ingram
  • Lupin Limited
  • Who should buy this report?

    The South Africa Central Nervous System (CNS) Therapeutic Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South Africa Central Nervous System (CNS) Therapeutic Market value chain can benefit from the information contained in a comprehensive market report.